Growth Metrics

Protalix BioTherapeutics (PLX) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -51.77%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 24.73%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -28.55%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 13.33%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -16.07%
7 Evaxion A 62.56 Bn 62.54 Bn - 21.66%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.88%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 36.53%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn -72.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -72.18%
Dec 31, 2025 -65.51%
Sep 30, 2025 8.38%
Jun 30, 2025 12.73%
Mar 31, 2025 4.84%
Sep 30, 2024 37.07%
Jun 30, 2024 -11.61%
Mar 31, 2024 11.12%
Dec 31, 2023 278.46%
Sep 30, 2023 14.68%
Jun 30, 2023 115.08%
Mar 31, 2023 32.61%
Dec 31, 2022 -1.29%
Sep 30, 2022 -20.63%
Jun 30, 2022 -20.75%
Mar 31, 2022 -17.76%
Dec 31, 2021 1.03%
Sep 30, 2021 -36.65%
Jun 30, 2021 6.15%
Mar 31, 2021 -21.71%
Dec 31, 2020 -79.57%
Sep 30, 2020 -26.06%
Jun 30, 2020 -48.05%
Mar 31, 2020 -33.43%
Dec 31, 2019 -34.49%
Sep 30, 2019 -25.24%
Jun 30, 2019 -22.84%
Mar 31, 2019 -23.06%
Dec 31, 2018 -20.89%
Sep 30, 2018 6.93%
Jun 30, 2018 -13.15%
Mar 31, 2018 -4.85%
Dec 31, 2017 -2.24%
Mar 31, 2017 -14.82%
Dec 31, 2016 -9.86%
Sep 30, 2016 -17.50%
Jun 30, 2016 18.14%
Mar 31, 2016 16.77%
Dec 31, 2015 13.64%
Sep 30, 2015 -11.98%
Jun 30, 2015 -9.98%
Mar 31, 2015 1.69%
Dec 31, 2014 26.58%
Mar 31, 2014 15.65%
Dec 31, 2013 34.01%
Sep 30, 2013 27.21%
Jun 30, 2013 -15.53%